Cutler Group’s Sensus Healthcare SRTS Stock Holding History

Cutler Group’s Portfolio SRTS Stock Details SRTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-101	Closed	–	–	4158
2023 Q1	$0	Sell	101 -709	-88%	-$5.09K	﹤0.01%	4671
2022 Q4	$6K	Buy	+810	New	+$7.31K	﹤0.01%	3085

Other funds holding SRTS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PCM

Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

CWM

Cahill Wealth Management Portage, Michigan $196M AUM 8.5% 1-Year Est. Return

Cutler Group's SRTS Position: Q2 2023 in Review

Cutler Group sold out of Sensus Healthcare (SRTS) in Q2 2023, closing a stake of 101 shares.

Cutler Group first reported a position in SRTS in Q4 2022 and held it in 2 quarters. The position peaked at $6K in Q4 2022. 49 funds tracked by Wall St. Rank hold SRTS as of Q2 2023.

Cutler Group reported no remaining Sensus Healthcare position as of Q2 2023 after selling out during the quarter.
Cutler Group sold 101 Sensus Healthcare shares in Q2 2023.
Cutler Group first reported a position in Sensus Healthcare in Q4 2022 and held it in 2 quarters.
Cutler Group's Sensus Healthcare position peaked at $6K in Q4 2022.
49 funds tracked by Wall St. Rank held Sensus Healthcare as of Q2 2023.

Based on Cutler Group's 13F filing for Q2 2023, filed 18 Jul 2023.